By Colin Kellaher

Shares of Cardiovascular Systems Inc. surged nearly 50% in premarket trading Thursday after the medical-device maker agreed to be acquired by Abbott Laboratories for about $890 million.

Abbott late Wednesday said it would pay $20 a share for Cardiovascular Systems, a 50% premium to Wednesday's closing price of $13.31 for the St. Paul, Minn., company.

Abbott, an Abbott Park, Ill., maker of healthcare products, said the addition of Cardiovascular Systems' atherectomy system will bolster its ability to provide better care for patients with peripheral- and coronary-artery disease.

Cardiovascular Systems shares were recently up 47% to $19.58 in premarket trading.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

February 09, 2023 06:09 ET (11:09 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Abbott Laboratories (NYSE:ABT)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024 Click aqui para mais gráficos Abbott Laboratories.
Abbott Laboratories (NYSE:ABT)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024 Click aqui para mais gráficos Abbott Laboratories.